Chowdhury Ananda, Feng Rentian, Tong Qin, Zhang Yuxun, Xie Xiang-Qun
Department of Pharmaceutical Sciences, School of Pharmacy, and Computational Chemical Genomics Screening Center, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Protein Expr Purif. 2012 Jun;83(2):128-34. doi: 10.1016/j.pep.2012.01.008. Epub 2012 Mar 3.
G protein coupled receptors (GPCRs) are key players in signal recognition and cellular communication making them important therapeutic targets. Large-scale production of these membrane proteins in their native form is crucial for understanding their mechanism of action and target-based drug design. Here we report the overexpression system for a GPCR, the cannabinoid receptor subtype 2 (CB2), in Escherichia coli C43(DE3) facilitated by two fusion partners: Mistic, an integral membrane protein expression enhancer at the N-terminal, and TarCF, a C-terminal fragment of the bacterial chemosensory transducer Tar at the C-terminal of the CB2 open reading frame region. Multiple histidine tags were added on both ends of the fusion protein to facilitate purification. Using individual and combined fusion partners, we found that CB2 fusion protein expression was maximized only when both partners were used. Variable growth and induction conditions were conducted to determine and optimize protein expression. More importantly, this fusion protein Mistic-CB2-TarCF can localize into the E. coli membrane and exhibit functional binding activities with known CB2 ligands including CP55,940, WIN55,212-2 and SR144,528. These results indicate that this novel expression and purification system provides us with a promising strategy for the preparation of biologically active GPCRs, as well as general application for the preparation of membrane-bound proteins using the two new fusion partners described.
G蛋白偶联受体(GPCRs)是信号识别和细胞通讯中的关键参与者,使其成为重要的治疗靶点。以天然形式大规模生产这些膜蛋白对于理解其作用机制和基于靶点的药物设计至关重要。在此,我们报告了一种GPCR——大麻素受体亚型2(CB2)在大肠杆菌C43(DE3)中的过表达系统,该系统由两个融合伴侣促成:Mistic,一种位于N端的整合膜蛋白表达增强剂,以及TarCF,细菌化学感应转导蛋白Tar的C端片段,位于CB2开放阅读框区域的C端。在融合蛋白的两端都添加了多个组氨酸标签以促进纯化。使用单个和组合的融合伴侣,我们发现只有当两个伴侣都使用时,CB2融合蛋白的表达才会最大化。进行了不同的生长和诱导条件以确定和优化蛋白表达。更重要的是,这种融合蛋白Mistic-CB2-TarCF可以定位于大肠杆菌膜中,并与包括CP55,940、WIN55,212-2和SR144,528在内的已知CB2配体表现出功能性结合活性。这些结果表明,这种新型的表达和纯化系统为我们提供了一种制备具有生物活性的GPCRs的有前景的策略,以及使用所描述的两个新融合伴侣制备膜结合蛋白的一般应用。